Hospira Inc. Fourth Quarter Earnings Sneak Peek
S&P 500 (NYSE:SPY) component Hospira, Inc. (NYSE:HSP) will unveil its latest earnings on Tuesday, February 14, 2012. Hospira is a global specialty pharmaceutical and medication delivery company that develops products that help improve the safety and productivity of patient care.
Hospira, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 45 cents per share, a decline of 41.6% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 47 cents. Between one and three months ago, the average estimate was unchanged. It has since dropped over the last month. Analysts are projecting profit to rise by 9.7% versus last year to $2.99.
Past Earnings Performance: The company met estimates last quarter after beating the forecasts in the prior two. In the third quarter, the company reported net income of 66 cents per share versus a mean estimate of profit of 66 cents per share. In the second quarter, the company beat estimates by 16 cents.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a decline of 4.6% in revenue from the year-earlier quarter to $946.4 million.
Analyst Ratings: Analysts seem relatively indifferent about Hospira with eight of 14 analysts surveyed maintaining a hold rating.
A Look Back: In the third quarter, the company swung to a loss of $88.9 million (54 cents a share) from a profit of $71.4 million (42 cents) a year earlier, meeting analyst expectations. Revenue rose 2.9% to $976.7 million from $949.3 million.
Hospira’s loss in the latest quarter followed profits in the previous three quarters. The company reported a profit of $143.6 million in the second quarter, a profit of $149.9 million in the first and a profit of $60.6 million in the fourth quarter of the last fiscal year.
The company’s revenue has risen for two straight quarters. In the second quarter, the figure rose 9.9%.
Stock Price Performance: During December 9, 2011 to February 8, 2012, the stock price had risen $6.68 (23.8%) from $28.07 to $34.75. It saw one of its worst periods between September 14, 2011 and September 22, 2011 when shares fell for seven-straight days, falling 13.1% (-$5.21) over that span. The stock price saw one of its best stretches over the last year between March 28, 2011 and April 5, 2011 when shares rose for seven-straight days, rising 4.7% (+$2.54) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories:
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com